Back

Bail-out glycoprotein IIb/IIIa inhibitors for coronary microvascular obstruction: guideline-indicated, but does harm outweigh benefit?

European Heart Journal

1 September 2024
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes IMAGING Cardiac Magnetic Resonance (CMR) Interventional Cardiology

Contributors

Jasmine Latter
Jasmine Latter

Author

Peter J McCartney
Peter J McCartney

Author

Colin Berry
Colin Berry

Author

University of Glasgow Glasgow , United Kingdom of Great Britain & Northern Ireland

You may be interested in
thumbnail
Congress Presentation
Cardioprotective strategy in ST-elevation acute myocardial infarction patients after reperfusion with percutaneous coronary intervention
28 August 2020
thumbnail
Webinar
Most recent changes on management of MINOCA. ESC 2023 Clinical Practice Guidelines - Webinar Series
22 November 2023
thumbnail
Congress Presentation
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study
1 September 2024
thumbnail
Congress Presentation
Efficacy and safety of local intracoronary drug delivery in the distal coronary bed as treatment of no-reflow phenomenon during percutaneous coronary intervention
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources